EODData

MEMBERSHIP REGISTER LOG IN

FRA, 2M7C: China Medical System Holdings Limited

14 Aug 2026
LAST:

1.280

CHANGE:
 0.00		OPEN:
1.280		HIGH:
1.280		ASK:
0.000		VOLUME:
0
CHG(%):
0.00		PREV:
1.280		LOW:
1.270		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
14 Aug 261.2801.2801.2701.2800
13 Aug 261.2901.2901.2801.2800
12 Aug 261.2901.3301.2801.2800
07 Aug 261.3401.3401.3401.3400
06 Aug 261.3101.3101.2901.2900
05 Aug 261.3001.3001.2801.2900
04 Aug 261.3001.3201.3001.3200
03 Aug 261.2801.2901.2801.2900
31 Jul 261.3001.3001.3001.3000
30 Jul 261.3201.3201.3101.3100

PROFILE

Name:China Medical System Holdings Limited
About:China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate depression. It also provides gastroenterology products, such as METOJECT, a methotrexate injection to treat severe recalcitrant disabling psoriasis and rheumatoid arthritis; LUMEBLUE, a methylthioninium chloride enteric-coated sustained-release tablets for colorectal lesion visualization; Salofalk for ulcerative colitis and Crohn's disease; Bioflor, a saccharomyces boulardii sachets for diarrhea; Combizym and Cidine for digestive enzymes; and Ursofalk, a ursodeoxycholic acid capsules to treat cholesterol gallstones. In addition, the company offers dermatology products, including ILUMETRI, a tildrakizumab injection for the treatment of plaque psoriasis; Aethoxysklerol, a polidocanol injection for sclerotherapy of various varicose veins; Hirudoid, a mucopolysaccharide polysulfate cream to treat blunt traumata; skin heling soothing product; and Hirudoid for acne-prone skin care, prevention, and enhancement of acne. Further, it provides Vmonalisa, modified sodium hyaluronate filler for mid to deep dermal implantation; augentropfen stulln mono eye drops for asthenopia; EyeOP1 glaucoma treatment device; and Elcitonin for Osteoporosis pain. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.
Sector:Healthcare
Address:Island Place Tower, North Point, Hong Kong
Website:https://web.cms.net.cn/zh/home/
ISIN:KYG211081248
LEI:529900Z57DVJXUBLHX66

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:16.25 
Forward P/E:8.08 
Price to Sales:0.39 
Price to Book:1.40 
Profit Margin:0.18 
Operating Margin:0.18 
Return on Assets:0.05 
Return on Equity:0.09 
DivYield:0.19 
Div/Share:0.27 
Revenue:1.06B 
EBITDA:2.194B 
Shares:2.44B 
Market Cap:3.123B 

TECHNICAL INDICATORS

MA5:1.291.1%
MA10:1.301.4%
MA20:1.323.4%
MA50:1.252.6%
MA100:1.312.1%
MA200:1.409.1%
RSI14:37.04 
WPR14:-100.00 
MTM14:-0.07
ROC14:-0.05 
ATR:0.02 
Week High:1.344.7%
Week Low:1.270.8%
Month High:1.398.6%
Month Low:1.279.1%
Year High:1.6528.9%
Year Low:1.1016.4%
Volatility:22.04 

RECENT SPLITS

Date Ratio
27 Apr 20123-2

RECENT DIVIDENDS

Date Amount
29 Aug 2025$0.02
28 Apr 2025$0.01
29 Aug 2024$0.02
13 May 2024$0.01
11 Sep 2023$0.04
03 May 2023$0.03
05 Sep 2022$0.04
26 Apr 2022$0.03
06 Sep 2021$0.04
29 Apr 2021$0.03